Construction and characterization of a recombinant human beta defensin 2 fusion protein targeting the epidermal growth factor receptor: in vitro study

Synthesis and purification of a toxin-linked conjugate targeting epidermal growth factor receptor in Escherichia coli

(2012) Chengyuan Ma et al.   PROTEIN EXPRESSION AND PURIFICATION

Human Defensins: Potential Tools for Clinical Applications

(2012) Jochen Winter et al.   Polymers

Expression systems of human β-defensins: vectors, purification and biological activities

(2010) L. L. Corrales-Garcia et al.   AMINO ACIDS

Human β-Defensin 2 and β-Defensin 3 Chimeric Peptides Reveal the Structural Basis of the Pathogen Specificity of Their Parent Molecules

(2010) Sascha Jung et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Human β-defensin 3 has immunosuppressive activityin vitroandin vivo

(2010) Fiona Semple et al.   EUROPEAN JOURNAL OF IMMUNOLOGY

Antibody-dependent cell-mediated cytotoxicity is induced by a single-chain Fv-protein III fusion in the presence of a rabbit anti-protein III polyclonal antibody

(2010) Susumu Hamada-Tsutsumi et al.   IMMUNOLOGY LETTERS

The anticancer activity of lytic peptides is inhibited by heparan sulfate on the surface of the tumor cells

(2009) Bodil Fadnes et al.   BMC CANCER

Defensins attenuate cytokine responses yet enhance antibody responses toPorphyromonas gingivalisadhesins in mice

(2009) Karl G Kohlgraf et al.   Future Microbiology

Expression and Purification of Glutathione Transferase-Small Ubiquitin-Related Modifier-Metallothionein Fusion Protein and Its Neuronal and Hepatic Protection against D-Galactose-Induced Oxidative Damage in Mouse Model

(2009) Y. Huang et al.   JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS